L6H9

L6H9 is a novel inhibitor of myeloid differentiation factor 2 (MD2), showed anti-inflammatory effects and cardiac protective activity. L6H9 attenuates LPS-induced acute lung injury in rats.


Cat. No.: EX-A5806	Purity: >98%

	Chemical structure of L6H9

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
5mg	385	In-stock
10mg	585	In-stock
25mg	885	In-stock
50mg	1285	In-stock
100mg	1785	In-stock
200mg	2585	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	1345412-48-7
Purity	>98%
Formula	C16H12F2O2
Mol Weight	274.2621
State	solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Wu, P, Yan, H, Qi, J, et al. L6H9 attenuates LPS-induced acute lung injury in rats through targeting MD2. Drug Dev Res. 2020; 81: 85– 92. https://doi.org/10.1002/ddr.21607.
CoA	CoA of L6H9


		Search